Aimei Health Technology (NASDAQ:AFJK) Shares Up 0.4% – Here’s Why

Aimei Health Technology Co., Ltd. (NASDAQ:AFJK) shares rose 0.4% on Tuesday . The company traded as high as $36.99 and last traded at $33.49. Approximately 4,450 shares were traded during trading, a decline of 34% from the average daily volume of 6,708 shares. The stock had previously closed at $33.34.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the company. Wall Street Zen raised Aimei Health Technology to a “sell” rating in a report on Saturday, January 17th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Aimei Health Technology in a research report on Monday, December 29th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the company currently has a consensus rating of “Sell”.

Aimei Health Technology Price Performance

The firm has a market capitalization of $204.96 million, a P/E ratio of 159.48 and a beta of -2.95. The firm’s fifty day moving average price is $51.98 and its 200-day moving average price is $27.80.

Hedge Funds Weigh In On Aimei Health Technology

Several hedge funds have recently modified their holdings of AFJK. Clear Street Group Inc. raised its stake in shares of Aimei Health Technology by 36.5% in the 4th quarter. Clear Street Group Inc. now owns 83,337 shares of the company’s stock worth $5,334,000 after buying an additional 22,294 shares in the last quarter. Jane Street Group LLC acquired a new position in Aimei Health Technology during the fourth quarter worth about $302,000. Geode Capital Management LLC bought a new stake in Aimei Health Technology in the fourth quarter worth about $413,000. Dakota Wealth Management acquired a new stake in Aimei Health Technology in the 4th quarter valued at about $406,000. Finally, Quarry LP lifted its holdings in Aimei Health Technology by 6.4% in the 3rd quarter. Quarry LP now owns 167,081 shares of the company’s stock valued at $1,891,000 after acquiring an additional 10,000 shares during the last quarter. 45.58% of the stock is currently owned by institutional investors and hedge funds.

About Aimei Health Technology

Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co, Ltd was incorporated in 2023 and is based in New York, New York.